Lower GSH levels are associated with elevation in many clotting elements and pro-coagulatory components, such as NETs, MMPs, NF-kB, and vessel endothelial changes, placing patients at a greater risk for microvascular thrombosis and platelet aggregation. This evidence concerns the gene NFKB1 and Venous thrombosis.